ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 150 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 24.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $949,000 | +190.2% | 50,360 | +81.0% | 0.00% | – |
| Q2 2019 | $327,000 | -3.5% | 27,821 | +12.0% | 0.00% | – |
| Q1 2019 | $339,000 | +33.5% | 24,842 | 0.0% | 0.00% | – |
| Q4 2018 | $254,000 | -34.0% | 24,842 | +7.3% | 0.00% | – |
| Q3 2018 | $385,000 | +5.2% | 23,144 | 0.0% | 0.00% | – |
| Q2 2018 | $366,000 | +13.0% | 23,144 | -9.4% | 0.00% | – |
| Q1 2018 | $324,000 | +45.3% | 25,547 | +31.1% | 0.00% | – |
| Q4 2017 | $223,000 | -3.5% | 19,487 | +2.5% | 0.00% | – |
| Q3 2017 | $231,000 | +30.5% | 19,011 | +22.7% | 0.00% | – |
| Q2 2017 | $177,000 | -44.0% | 15,496 | +2.6% | 0.00% | – |
| Q1 2017 | $316,000 | -0.6% | 15,096 | -1.3% | 0.00% | – |
| Q4 2016 | $318,000 | -1.2% | 15,289 | +51.6% | 0.00% | – |
| Q3 2016 | $322,000 | +17.5% | 10,087 | -9.7% | 0.00% | – |
| Q2 2016 | $274,000 | +35.0% | 11,171 | +33.8% | 0.00% | – |
| Q1 2016 | $203,000 | +14.7% | 8,349 | +57.6% | 0.00% | – |
| Q4 2015 | $177,000 | +25.5% | 5,296 | +16.2% | 0.00% | – |
| Q3 2015 | $141,000 | -15.1% | 4,556 | +34.2% | 0.00% | – |
| Q2 2015 | $166,000 | +418.8% | 3,396 | +214.4% | 0.00% | – |
| Q1 2015 | $32,000 | – | 1,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |